By Zachary Zagger ( November 17, 2014, 1:36 PM EST) -- Pfizer Inc. has reached an up to $2.9 billion deal with Germany's Merck KGaA to jointly develop a new cancer drug, the companies said Monday, bolstering Pfizer's cancer portfolio after it dropped a push to acquire British drug giant AstraZeneca PLC earlier this year....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.